Pharmaceutical News and Articles

2017 to 2021 Saw Increase in Clinically Diagnosed Depression in Youth

Clinically diagnosed depression increased from 2017 to 2021 in children, adolescents, and young adults, with a higher increase during the pandemic, according to

Incident Stroke Tied to Acute, Accelerated Long-Term Cognitive Decline

For older stroke survivors, incident stroke is associated with acute and accelerated long-term cognitive decline, according to a study published online Oct. 2 i

Gilead Signs Royalty-Free Voluntary Licensing Agreements with Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries

Foster City, Calif. October 2, 2024 Gilead Sciences, Inc. (Nasdaq GILD) today announced that it has signed non-exclusive, royalty-free voluntary licensing agree

Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

NEW HAVEN, Conn., Oct. 3, 2024. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbup

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Most Americans Struggle With Poor Sleep, Daytime Drowsiness: Survey

Nearly 8 in 10 Americans go through the day in a fog that interferes with their jobs, their moods and their relationships. Chalk it up to sleepiness A new surve

Record Rate of U.S. Kindergartners Failed to Get Recommended Vaccines

In yet another sign that childhood vaccinations can t be taken for granted, new government data shows that a record number of kindergartners were exempted from

Stem Cell Therapy Might Repair Vision-Robbing Holes in Retinas

Japanese researchers have successfully used a transplant of human stem cells to close a hole in a key part of a monkey s retina. They say the achievement could

Prostatic Artery Embolization Offers Lasting Benefit for BPH

For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a study pub